136 related articles for article (PubMed ID: 17907098)
1. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
Park HW; Kim Y; Kim KH; Jeong HJ; Shin MH; Rozen S; Mauer M
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):110-7. PubMed ID: 17907098
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation.
Park HW; Kim Y; Kim KH; Rozen S; Najafian B; Mauer M
Nephrol Dial Transplant; 2012 Jan; 27(1):107-14. PubMed ID: 21633100
[TBL] [Abstract][Full Text] [Related]
3. A re-evaluation of the renal ablation model of progressive renal disease in rats.
Kim KH; Kim Y; Park HW; Jeong HJ; Mauer M
J Nephrol; 2003; 16(2):196-202. PubMed ID: 12768066
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
[TBL] [Abstract][Full Text] [Related]
6. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
Fujihara CK; Malheiros DM; Zatz R
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
[TBL] [Abstract][Full Text] [Related]
7. AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury.
Machado FG; Poppi EP; Fanelli C; Malheiros DM; Zatz R; Fujihara CK
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1345-53. PubMed ID: 18400868
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
Fanelli C; Fernandes BH; Machado FG; Okabe C; Malheiros DM; Fujihara CK; Zatz R
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
10. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Gonçalves AR; Fujihara CK; Mattar AL; Malheiros DM; Noronha Ide L; de Nucci G; Zatz R
Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
[TBL] [Abstract][Full Text] [Related]
11. An extremely high dose of losartan affords superior renoprotection in the remnant model.
Fujihara CK; Velho M; Malheiros DM; Zatz R
Kidney Int; 2005 May; 67(5):1913-24. PubMed ID: 15840039
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
13. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
14. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
17. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388
[TBL] [Abstract][Full Text] [Related]
18. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
19. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
[TBL] [Abstract][Full Text] [Related]
20. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]